Overexpression of OSM and IL-6 Impacts the Polarization of Pro-fibrotic Macrophages and the Development of Bleomycin-induced Lung Fibrosis
Authors
Affiliations
Although recent evidence indicates that gp130 cytokines, Oncostatin M (OSM) and IL-6 are involved in alternative programming of macrophages, their role in lung fibrogenesis is poorly understood. Here, we investigated the effect of transient adenoviral overexpression of OSM or IL-6 in mice during bleomycin-induced lung fibrosis. Lung fibrosis and M2-like macrophage accumulation were assessed by immunohistochemistry, western blotting, gene expression and flow cytometry. Ex-vivo isolated alveolar and bone marrow-derived macrophages were examined for M2-like programming and signalling. Airway physiology measurements at day 21 demonstrated that overexpression of OSM or IL-6 exacerbated bleomycin-induced lung elastance, consistent with histopathological assessment of extracellular matrix and myofibroblast accumulation. Flow cytometry analysis at day 7 showed increased numbers of M2-like macrophages in lungs of mice exposed to bleomycin and OSM or IL-6. These macrophages expressed the IL-6Rα, but were deficient for OSMRβ, suggesting that IL-6, but not OSM, may directly induce alternative macrophage activation. In conclusion, the gp130 cytokines IL-6 and OSM contribute to the accumulation of profibrotic macrophages and enhancement of bleomycin-induced lung fibrosis. This study suggests that therapeutic strategies targeting these cytokines or their receptors may be beneficial to prevent the accumulation of M2-like macrophages and the progression of fibrotic lung disease.
Advances in Interleukin-6 Family Cytokines and the Role in Respiratory Diseases.
Ji T, Huang G, Cao Y, Gao Y, Gao X J Inflamm Res. 2025; 18:3125-3141.
PMID: 40059944 PMC: 11889408. DOI: 10.2147/JIR.S508031.
Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets.
Li J, Dang Y, Liu M, Gao L, Lin H Int J Biol Sci. 2025; 21(2):544-564.
PMID: 39781450 PMC: 11705629. DOI: 10.7150/ijbs.102297.
Lim Y, Quinn R, Bharti K, Ferrer M, Zarkoob H, Song M Biofabrication. 2024; 17(1).
PMID: 39622178 PMC: 11638742. DOI: 10.1088/1758-5090/ad998c.
Niu Y, Liu S, Qiu Q, Fu D, Xiao Y, Liang L Arthritis Res Ther. 2024; 26(1):184.
PMID: 39468670 PMC: 11520069. DOI: 10.1186/s13075-024-03415-5.
Astrab L, Skelton M, Caliari S bioRxiv. 2024; .
PMID: 39463963 PMC: 11507682. DOI: 10.1101/2024.10.13.618034.